120 related articles for article (PubMed ID: 3162384)
1. Substrate-related potent inhibitors of brain metalloendopeptidase.
Orlowski M; Michaud C; Molineaux CJ
Biochemistry; 1988 Jan; 27(2):597-602. PubMed ID: 3162384
[TBL] [Abstract][Full Text] [Related]
2. Active site directed N-carboxymethyl peptide inhibitors of a soluble metalloendopeptidase from rat brain.
Chu TG; Orlowski M
Biochemistry; 1984 Jul; 23(16):3598-603. PubMed ID: 6383469
[TBL] [Abstract][Full Text] [Related]
3. Substrate and inhibitor studies of thermolysin-like neutral metalloendopeptidase from kidney membrane fractions. Comparison with bacterial thermolysin.
Pozsgay M; Michaud C; Liebman M; Orlowski M
Biochemistry; 1986 Mar; 25(6):1292-9. PubMed ID: 3516218
[TBL] [Abstract][Full Text] [Related]
4. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids.
Steer D; Lew R; Perlmutter P; Smith AI; Aguilar MI
Biochemistry; 2002 Sep; 41(35):10819-26. PubMed ID: 12196021
[TBL] [Abstract][Full Text] [Related]
6. A new class of potent reversible inhibitors of metallo-proteinases: C-terminal thiol-peptides as zinc-coordinating ligands.
Peters K; Jahreis G; Kotters EM
J Enzyme Inhib; 2001 Oct; 16(4):339-50. PubMed ID: 11916139
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunological properties of a membrane-bound brain metalloendopeptidase: comparison with thermolysin-like kidney neutral metalloendopeptidase.
Almenoff J; Orlowski M
J Neurochem; 1984 Jan; 42(1):151-7. PubMed ID: 6417277
[TBL] [Abstract][Full Text] [Related]
8. The effect of changing the hydrophobic S1' subsite of thermolysin-like proteases on substrate specificity.
de Kreij A; van den Burg B; Veltman OR; Vriend G; Venema G; Eijsink VG
Eur J Biochem; 2001 Sep; 268(18):4985-91. PubMed ID: 11559368
[TBL] [Abstract][Full Text] [Related]
9. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.
Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP
Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177
[TBL] [Abstract][Full Text] [Related]
10. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
11. Zinc coordination and substrate catalysis within the neuropeptide processing enzyme endopeptidase EC 3.4.24.15. Identification of active site histidine and glutamate residues.
Cummins PM; Pabon A; Margulies EH; Glucksman MJ
J Biol Chem; 1999 Jun; 274(23):16003-9. PubMed ID: 10347149
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of inhibitors incorporating beta -amino acids of metalloendopeptidase EC 3.4.24.15.
Steer DL; Lew RA; Perlmutter P; Smith AI; Aguilar MI
J Pept Sci; 2000 Sep; 6(9):470-7. PubMed ID: 11016884
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde and ketone substrate analogues inhibit the collagenase of Clostridium histolyticum.
Grobelny D; Galardy RE
Biochemistry; 1985 Oct; 24(22):6145-52. PubMed ID: 3002433
[TBL] [Abstract][Full Text] [Related]
14. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.
Shrimpton CN; Abbenante G; Lew RA; Smith I
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):351-6. PubMed ID: 10620512
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity differences between recombinant rat testes endopeptidase EC 3.4.24.15 and the native brain enzyme.
Lew RA; Hey NJ; Tetaz TJ; Glucksman MJ; Roberts JL; Smith AI
Biochem Biophys Res Commun; 1995 Apr; 209(3):788-95. PubMed ID: 7733970
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
18. A novel synthetic inhibitor of endopeptidase-24.15.
Ukai Y; Li Q; Ito S; Mita S
J Enzyme Inhib; 1996 Aug; 11(1):39-49. PubMed ID: 9204395
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the thermolysin-like cleavage of biologically active peptides by Xenopus laevis peptide hormone inactivating enzyme.
Joudiou C; Carvalho KM; Camarao G; Boussetta H; Cohen P
Biochemistry; 1993 Jun; 32(23):5959-66. PubMed ID: 8507636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
